Shmuel Shoham | sciencenewsnet.in

Breaking News

A new study highlights microalgae as sustainable ingredients for food and pharmaceutical applications

Nitric oxide treatment preserves fresh walnuts, reduces decay, and maintains quality

Researchers Develop High-Tech Methods to Stem the Flow of Fentanyl

Research Shows Cleveland Clinic’s Therapeutic Virtual Yoga Program Can Be Effective for Chronic Low Back Pain

CSUDH Political Experts Available for Election Coverage

Political Science Faculty Weigh in on 2024 Election

Long Beach Lakewood Orthopedic Institute Joins Commons Clinic, Strengthening Comprehensive Orthopedic Care Services in Long Beach

National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment

Fueling greener aviation with hydrogen

Don’t Let Diabetes Dim Your Vision

02 Nov, 2024

Johns Hopkins Receives $35 Million in Funding from Department of Defense for Covid-19 Blood Plasma Trials

July 30, 2020 sarah JonasAnnouncement

Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), on behalf of the Defense Health Agency, for two nationwide clinical trials to test the effectiveness of a convalescent blood plasma outpatient treatment. The treatment is a transfusion of a blood product from COVID-19 survivors that contains antibodies that may help the patient’s immune system fight the virus.